Tag:
pain
Latest Headlines
Latest Headlines
Intellipharmaceutics raises $5M to adance tamper-resistant oxycodone
Canada's Intellipharmaceutics International ($IPCI), a specialist in controlled-release drug formulations, is raising $5 million to fuel anticipated U.S. clinical trials for Rexista, a patented version of the highly addictive pain killer oxycodone designed to resist abuse.
With J&J deal undone, Orexo revamps drug delivery tech development
Sweden's Orexo will slash jobs and focus on three development programs that rely on enhancing already-approved treatments.
Takeda abandons Euro rights to Durect's controlled-release pain drug
For the second time this year, Durect ($DRRX) faces a setback over its controlled-release anti-pain drug Posidur. The Cupertino, CA-based company disclosed that its European development and marketing
Study: Eli Lilly's Cymbalta sputters out for nearly 16% of depression patients
About 16% of patients on Eli Lilly's ( $LLY ) antidepressant drug Cymbalta either didn't improve or became worse on the treatment, according to a new study. On the surface, the news is a potential
